(HealthDay)—Adults who receive a provider recommendation for COVID-19 vaccination are more likely to have received one or more doses of COVID-19 vaccine, according to research published in the Dec. 17 issue of the U.S. Centers for Disease Control and PreventionMorbidity and Mortality Weekly...
First, COVID-19 vaccine administration policy; secondly, knowledge dissemination and plan to address obstacles of public acceptances towards the vaccine proactively; thirdly, better implementation programs by the government and fourthly, using local research expertise for vaccine developmen...
You might want to consider getting the pneumococcal vaccine. Adults have many things to consider and keep them busy. Without an explanation of why they should take the time to consider vaccination, or a clear indication that the HCP believes that it is important for them, they likely will not...
The COVID-19 pandemic has brought vaccination to the forefront of discourse on public health. The rapid speed of COVID-19 vaccine development, utilization of novel technology, and an atmosphere of politicized misinformation have created a perfect storm for vaccine hesitancy. As early adopters of ...
We tested different approaches doctors could take to talk to their patients about the COVID-19 vaccine. While all of the messages included statements that the patient was eligible for a safe and effective vaccine, they differed by what the doctor said following this information. ...
Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control and Prevention. In a statement released Wednesday, the CDC said the second dose should be received...
HELSINKI, May 5 (Xinhua) -- The Finnish National Institute for Health and Welfare (THL) on Thursday recommended municipalities provide a fourth dose of COVID-19 vaccine to those who are undergoing home or family care, as well as to elderly people with impaired health. ...
The case for making the booster recommendation now With more clinical trial data about to roll in, and initial results from Pfizer’s booster study currently under review by the FDA, why did the White House opt to announce their recommendation for Covid vaccine booster shots now?
This recommendation is based on the currently available data, including an understanding of circulating variants and their impact on disease severity and vaccine effectiveness, current trends in COVID-19 community levels within the United States, and projections of COVID-19 trends in the coming months...
The current landscape of COVID‐19 vaccines and the strategies for accelerating vaccine development and approval are reviewed. Proposals to enhance variants monitoring and the establishment of the strain recommendation mechanism are made. This... D Sipp - Faculty Opinions – Post-Publication Peer Revie...